首页> 外文期刊>European journal of heart failure: journal of the Working Group on Heart Failure of the European Society of Cardiology >Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease
【24h】

Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease

机译:MinerA类激素受体拮抗剂耐受性研究-心力衰竭(ARTS-HF)的原理和设计:在患有糖尿病和/或慢性肾脏病的慢性心力衰竭加重的患者中,使用氟雷农和依普利农的随机研究

获取原文
获取原文并翻译 | 示例
           

摘要

AimsTo investigate the safety and potential efficacy of the novel non-steroidal mineralocorticoid receptor antagonist finerenone in patients with worsening chronic heart failure and reduced left ventricular ejection fraction (HFrEF) and at high risk of hyperkalaemia and worsening renal dysfunction.
机译:目的探讨新型非甾体类盐皮质激素受体拮抗剂氟雷酮在慢性心力衰竭加重,左心室射血分数(HFrEF)降低,高钾血症高危和肾功能不全高危患者中的安全性和潜在疗效。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号